p53-Independent Inhibition of Proliferation and p21Waf1/Cip1-Modulated Induction of Cell Death by the Antioxidants N-acetylcysteine and Vitamin E1

Neoplasia

Volumn 1, Issue 6, 1999, Pages 544-556

  Nargi, Jennifer L ^a   Ratan, Rajiv R ^b,c   Griffin, Diane E ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Apoptosis; Colorectal; N acetylcysteine; p21Waf1 Cip1; p53

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DIVISION; DRUG EFFECT; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; VITAMIN E;

EID: 0033287224     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Konings E, and Greenberg ER (1998). Antioxidant supplements and colorectal cancer. Nutrition 14, 245-247.
2. Parker SL (1996). Cancer statistics. Ca-Cancer J Clin 46, 5-27.
3. Vogelstein B, and Kinzler KW (1993). The multistep nature of cancer. Trends Genet 9, 138-141.
4. Ferrari G, Yan CYI, and Greene LA (1995). N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 14, 2857-2866.
5. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ (1997). Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652.
6. Lee JS, Kypreos KE, and Sonenshein GE (1998). Synchronization of cultured vascular smooth muscle cells following reversal of quiescence induced by treatment with the antioxidant N-acetylcysteine. Exp Cell Res 239, 447-453.
7. Albini A, D'Agostini F, Giunciuglio D, Paglieri I, Balansky R, and De Flora S (1995). Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int J Cancer 61, 121-129.
8. Balansky RM, and De Flora S (1998). Chemoprevention by N-acetylcysteine of urethane-induced clastogenicity and lung tumors in mice. Int J Cancer 77, 302-305.
9. D'Agostini F, Bagnasco M, Giunciuglio D, Albini A, and De Flora S (1998). Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice. Int J Oncol 13, 217-224.
10. De Flora S, Izzotti A, D'Agostini F, and Cesarone CF (1991). Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med 91, 122S-130S.
11. Mayer M, and Noble M (1994). N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 91, 7496-7500.
12. Ratan RR, Murphy TH, and Baraban JM (1994). Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci 14, 4385-4392.
13. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, and Korsmeyer SJ (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
14. Lin K-I, Lee S-H, Narayanan R, Baraban JM, Hardwick JM, and Ratan RR (1995). Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol 131, 1149-1161.
15. Johnson TM, Yu Z-X, Ferrans VJ, Lowenstein RA, and Finkel T (1996). Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci USA 93, 11848-11852.
16. Liu M, Pelling JC, Ju J, Chu E, and Brash DE (1993). Antioxidant action via p53-mediated apoptosis. Cancer Res 58, 1723-1729.
17. waf1/cip1 via C/EBPβ. Nat Med 3, 1233-1241.
18. Tsai J-C, Jain M, Hsieh C-M, Lee W-S, Yoshizumi M, Patterson C, Perrella MA, Cooke C, Wang H, Haber E, Schlegel R, and Lee M-E (1996). Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J Biol Chem 271, 3667-3670.
19. Meister A (1988). Glutathione metabolism and its selective modification. J Biol Chem 263, 17205-17208.
20. Aruoma OI, Halliwell B, Hoey BM, and Butler J (1989). The antioxidant action of N-acetylcysteine, its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorous acid. Free Radical Biol Med 6, 593-597.
21. Hjortso E, Fomsgaard JS, and Fogh-Andersen N (1990). Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally? Eur J Clin Pharmacol 39, 29-31.
22. Sakaida I, Kyle ME, and Farber JL (1989). Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress. Mol Pharmacol 37, 435-442.
23. Connor JR, and Benkovic SA (1992). Iron regulation in the brain: histochemical, biochemical, and molecular considerations. Ann Neurol 32, S51-S61.
24. Gille JJP, vanBerkel CGM, and Joenje H (1992). Effect of iron chelators on the cytotoxic and genotoxic action of hyperoxia in Chinese hamster ovary cells. Mutat Res 275, 31-39.
25. Hartley A, Cooper JM, and Schapira AHV (1993). Iron induced oxidative stress and mitochondrial dysfunction relevance to Parkinson's disease. Brain Res 627, 349-353.
26. Schreck R, and Baeuerle PA (1991). A role for oxygen radicals as second messengers. Trends Cell Biol 1, 39-42.
27. Turley JM, Funakoshi S, Ruscetti FW, Kasper J, Murphy WJ, Longo DL, and Birchenall-Roberts MC (1995). Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor β. Cell Growth Differ 6, 655-663.
28. Nobel CSI, Kimland M, Lind B, Orrenius S, and Slater AFG (1995). Dithiocarbamates induce apoptosis in thymocytes by raising the intracellular level of redox-active copper. J Biol Chem 270, 26202-26208.
29. Burton GW (1994). Vitamin E: molecular and biological function. Proc Nutr Soc 53, 251-262.
30. Bowry VW, Ingold KU, and Stocker R (1992). Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J 288, 341-344.
31. Burdon RH (1996). Control of cell proliferation by reactive oxygen species. Biochem Soc Trans 24, 1028-1032.
32. Jacobson MD (1996). Reactive oxygen species and programmed cell death. Trends Biochem Sci 21, 83-86.
33. Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
34. Polyak K, Waldman T, He T-C, Kinzler KW, and Vogelstein B (1996). Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10, 1945-1952.
35. Polyak K, Xia Y, Zweier JL, Kinzler KW, and Vogelstein B (1997). A model for p53-induced apoptosis. Nature 389, 300-305.
36. Burdon RH, and Gill V (1993). Cellularly generated active oxygen species and HeLa cell proliferation. Free Radical Res Commun 19, 203-213.
37. Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14, 929-935.
38. Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, and Bradley A (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294.
39. Fattman CL, An B, and Dou QP (1997). Characterization of interior cleavage of retinoblastoma protein in apoptosis. J Cell Biochem 67, 399-408.
40. Dou QP (1997). Putative roles of retinoblastoma protein in apoptosis. Apoptosis 2, 5-18.
41. An B, and Dou QP (1996). Cleavage of retinoblastoma protein during apoptosis: an interleukin 1β-converting enzyme-like protease as candidate. Cancer Res 56, 438-442.
42. Tan X, and Wang JY (1998). The caspase-RB connection in cell death. Trends Cell Biol 8, 116-120.
43. Janicke RU, Walker PA, Lin XY, and Porter AG (1996). Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 15, 6969-6978.
44. Kuerbitz SJ, Plunkett BS, Walsh WV, and Kastan MB (1992). Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89, 7491-7495.
45. Baker SJ, Markowitz S, Fearon ER, Willson JKV, and Vogelstein B (1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915.
46. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, and Cho KR (1993). Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90, 3988-3992.
47. 1 arrest in human cancer cells. Cancer Res 55, 5187-5190.
48. Waldman T, Lengauer C, Kinzler KW, and Vogelstein B (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716.
49. 2 in cultured endothelial cells. Arch Biochem Biophys 302, 348-355.
50. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, and Vogelstein B (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
51. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF, Nakamura Y, White R, and Vogelstein B (1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244, 217-221.
52. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, and Vogelstein B (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature 342, 705-708.
53. Graeber TG, Peterson JF, Tsai M, Monica K, Fomace AJ, and Giaccia AJ (1994). Hypoxia induced accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14, 6264-6277.
54. Yan CYI, Ferrari G, and Greene LA (1995). N-acetylcysteine-promoted survival of PC12 cells is glutathione-independent but transcription-dependent. J Biol Chem 270, 26827-26832.
55. Harper JW, Adami G, Wei N, Keyomarsi K, and Elledge SJ (1993). The 21 Kd Cdk interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
56. Xiong Y, Hannon GJ, Zhang GJ, Casso D, Kobayashi R, and Beach D (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704.
57. Noda A, Ning Y, Venable SF, Pereira-Smith OM, and Smith JR (1994). Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211, 90-98.
58. Totoshima H, and Hunter T (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74.
59. Polyak K, Lee M-H, Erdjument-Bromage H, Tempst P, and Massague J (1994). Cloning of p27 KlP1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78, 59-66.
60. CIP1 Cdk-inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9, 650-662.
61. Lee M-H, Reynisdottir I, and Massague J (1995). Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9, 639-649.
62. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, and Swindell E (1995). Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6, 387-400.
63. Serrano M, Hannon GJ, and Beach D (1993). A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707.
64. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature 371, 257-261.
65. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, and Vogelstein B (1994). Deletion of p16 and p15 genes in brain tumors. Cancer Res 54, 6353-6358.
66. INK4b/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8, 2939-2952.
67. Hirai H, Roussel MF, Kato JY, Ashmun RA, and Sherr C (1995). Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin dependent kinases Cdk4 and Cdk6. Mol Cell Biol 15, 2672-2681.
68. ink4. Mol Cell Biol 15, 2682-2688.
69. Taya Y (1997). RB kinases and RB-binding proteins: new points of view. Trends Biochem Sci 22, 14-17.
70. Diederich L, Fotedar A, and Fotedar R (1998). Proteolytic cleavage of retinoblastoma protein upon DNA damage and Fas-mediated apoptosis. Cell Biol Toxicol 14, 133-140.
71. Fattman CL, An B, Sussman L, and Dou QP (1998). p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells. Cancer Lett 130, 103-113.
72. Slebos RJC, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, and Cho KR (1994). p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci USA 91, 5320-5324.
73. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, and Trent JM (1993). Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 90, 3113-3117.
74. Cerutti PA (1985). Prooxidant states and tumor promotion. Science 227, 375-381.
75. Borek C, and Troll W (1983). Modifiers of free radicals inhibit in vitro the oncogenic actions of x-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorbol 13-acetate. Proc Natl Acad Sci U S A 80, 1304-1307.
76. Kensler TW, Bush DM, and Kozumbo WJ (1983). Inhibition of tumor promotion by a biomimetic superoxide dismutase. Science 221, 75-77.
77. Behl C, Davis JB, Lesley R, and Schubert D (1994). Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
78. Gorospe M, and Holbrook NJ (1996). Role of p21 in prostaglandin A2-mediated cellular arrest and death. Cancer Res 56, 475-479.
79. Wat1/Cip1 against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol 16, 6654-6660.
80. Waf1 is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16, 1335-1341.
81. Waf1/Cip1/Sdi1 lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene 16, 705-712.
82. Jiang W, Kahn SM, Guillem JG, Lu S-H, and Weinstein IB (1989). Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene 4, 923-928.
83. Capon DJ, Seeburg PH, McGrath JP, Hayflick JS, Edman U, Levinson AD, and Goeddel DV (1983). Activation of Ki-ras2 gene In human colon and lung carcinomas by two different point mutations. Nature 304, 507-513.
84. Clem RJ, Cheng EH, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA, and Hardwick JM (1998). Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA 95, 554-559.
85. Cheng EH-Y, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, and Hardwick JM (1997). Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966-1968.
86. Bernai SD, Lampidis TJ, McIsaac RM, and Chen LB (1983). Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. Science 222, 169-172.
87. Darzynkiewicz Z, Traganos F, Staiano-Coico L, Kapuscinski J, and Melamed MR (1982). Interactions of rhodamine 123 with living cells studied by flow cytometry. Cancer Res 42, 799-806.
88. Johnson LV, Summerhayes IC, and Chen LB (1982). Decreased uptake and retention of rhodamine 123 by mitochondria in feline sarcoma virus-transformed mink cells. Cell 28, 7-14.
89. Lampidis TJ, Bernal SD, Summerhayes IC, and Chen LB (1983). Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res 43, 716-720.
90. Modica-Napolitano JS, Weiss MJ, Chen LB, and Aprille JR (1984). Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria. Biochem Biophys Res Commun 118, 717-723.
91. Bernal SD, Lampidis TJ, Summerhayes IC, and Chen LB (1982). Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. Science 218, 1117-1119.
92. Rautalahti M, and Huttunen J (1993). Antioxidants and carcinogenesis. Ann Med 25, 435-441.